The AKLIS brand, founded in 2012 (United Kingdom), from 1722 sister brands and 17477 competing brands. AKLIS is owned by GSK PLC, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. The sector of AKLIS is Drug Manufacturers.
Investment simulator :
Portfolio valuation
GSK PLC
(AKLIS)
over 5 years*
EUR 16.30